Labshake search
Citations for Tocris :
151 - 200 of 218 citations for Steroid Receptor Co Factor Peptide since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
Sexual differences in neuronal and synaptic properties across subregions of the mouse insular cortexbioRxiv - Neuroscience 2023Quote: ... were recorded at −70mV in presence of 20□μM CNQX (6-Cyano-7-nitroquinoxaline-2,3-dione disodium, an AMPA receptor antagonist, Tocris) and L-APV 50 μM (DL-2-Amino-5-phosphonopentanoic acid ...
-
bioRxiv - Neuroscience 2020Quote: ... the N3 media was further supplemented with two factors: SB-431542 (5 µM, Tocris, 1614) and LDN-193189 (100 nM ...
-
bioRxiv - Neuroscience 2021Quote: ... fish were co-exposed to 10 μM DL-TBOA (Tocris; Cat. No.1223) + 0.1% DMSO or 0.1% DMSO alone ...
-
bioRxiv - Immunology 2020Quote: ... cells were co-treated with 1 mM of L-NAME hydrochloride (TOCRIS, 0665) or 100 μM of 1400W dihydrochloride (Enzo Life Sciences ...
-
bioRxiv - Neuroscience 2019Quote: ... RVKR (Deconoyl-RVKR-CMK) and the KYL peptide were purchased from Tocris.
-
bioRxiv - Neuroscience 2021Quote: ... an agonist of group II metabotropic glutamate receptors (mGluR2/3) that reduces release probability in mossy fiber terminals (1 μM, Tocris)(Kamiya et al. ...
-
bioRxiv - Neuroscience 2021Quote: ... synaptic GABA currents were recorded in perfusing aCSF containing the glutamate receptor antagonist kynurenic acid (3 mM, Tocris, Ellisville, MO). Recorded neurons were initially held at −70 mV for interneurons and −60 mV for GCs and SGCs and the response to 500 milli-second positive and negative current injections were examined to determine active and passive characteristics ...
-
bioRxiv - Neuroscience 2020Quote: Current-clamp recordings were performed using an BVC-700A amplifier (Dagan, Minneapolis, USA) with standard ACSF solution at 34°C containing the GABAB-receptor blocker CGP55845 (1 µM, Tocris). Recording pipettes with a resistance of 3-5 MΩ were pulled with a DMZ universal electrode puller (Zeitz-Instruments Vertriebs-GmbH ...
-
bioRxiv - Neuroscience 2021Quote: ... Glutamatergic neurons were identified by their characteristic EPSC time course and by sensitivity of EPSC to application of glutamate receptor antagonist kynurenic acid (Tocris). Synaptic currents were acquired at 10 kHz using pClamp 10.2 software (Molecular Devices ...
-
bioRxiv - Neuroscience 2021Quote: ... In some experiments fast synaptic transmission was blocked with continuous bath-application of the AMPA receptor blocker DNQX (25 μM; Tocris), the NMDA receptor blocker D-AP5 (25 μM ...
-
bioRxiv - Neuroscience 2021Quote: ... were dissolved in magnesium-free HEPES-aCSF in the presence of non-NMDA glutamate receptor blockers (CNQX, Tocris, 0190, 40 μM; Nimodipine, Tocris, 0600 ...
-
bioRxiv - Neuroscience 2021Quote: Potassium currents were isolated pharmacologically during whole-cell voltage-clamp recordings by blocking fast sodium and calcium channels as well as ionotropic receptors for GABA and glutamate (2 µM tetrodotoxin (TTX, Tocris), 300 µM NiCl2 ...
-
bioRxiv - Pharmacology and Toxicology 2020Quote: ... Kinin receptors involvement in NO production by the tested peptides was assessed by selective antagonism of B1 and B2 receptors with Lys-(des-Arg9-Leu8-BK-(1-9) (B1RB) and HOE-140 (Tocris) (B2RB) ...
-
bioRxiv - Neuroscience 2020Quote: ... Pluripotent hESCs were incubated with small molecules to start the dual SMAD inhibition: BMP and TGF-b receptors were pharmacologically blocked with 100 nM LDN193189 (Stemgent) and 10 mM SB431542 (Tocris), respectively ...
-
Serotonin Modulates an Inhibitory Input to the Central Amygdala from the Ventral Periaqueductal GraybioRxiv - Neuroscience 2022Quote: ... the ability of 5HT2C receptors to modulate GABA release from this pathway following fear learning was investigated by administering the 5HT2C receptor antagonist SB242084 (Tocris, Minneapolis ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... 0.3 or 1 mg/kg of the mGlu2/3 receptor agonist LY379268 (Cat No.: 2453, Batch No.: 9B/232416, CAS No.: 191471-52-0, Tocris Bioscience ...
-
bioRxiv - Neuroscience 2023Quote: ... and 10 μM 6-Imino-3-(4-methoxyphenyl)-1(6H)-pyridazinebutanoic acid hydrobromide (SR95531; GABAA receptor antagonist, all from Tocris). The resting membrane potential was measured after whole-cell configuration was achieved ...
-
bioRxiv - Developmental Biology 2023Quote: ... The average baseline EPSP was established with a minimum of 20 sweeps before adding glutamate receptor antagonists (10 μM NBQX (Tocris) and 10 μM CPP (Tocris) ...
-
Sexual differences in neuronal and synaptic properties across subregions of the mouse insular cortexbioRxiv - Neuroscience 2023Quote: ... were recorded at −70 mV and isolated by using the GABAA receptor blocker gabazine 10 mM (SR 95531 hydrobromide; Tocris).
-
bioRxiv - Neuroscience 2023Quote: ... were dissolved in HEPES-aCSF in the presence of non-NMDA glutamate receptor blockers (CNQX, Tocris, 0190, 40 µM; Nimodipine, Tocris, 0600 ...
-
bioRxiv - Neuroscience 2023Quote: ... sIPSC recordings were performed in voltage clamp mode in the presence of 20 μM AMPA/Kainate receptor antagonist CNQX (Tocris) and 50 μM NMDA receptor antagonist AP5 (Tocris) ...
-
bioRxiv - Neuroscience 2024Quote: ... another group of animals received an ip injection of WIN55,212-2 (0.5 mg/kg) along with CB1 receptor antagonist SR141716A (0.5 mg/kg, ip) (Tocris Bioscience, Bristol, UK). Rats were randomly selected for each group ...
-
bioRxiv - Neuroscience 2023Quote: ... we recorded at −70mV for 48s and for 24s in the presence of the AMPA-receptor antagonist NBQX (3μM) (Tocris Bioscience) diluted in extracellular solution ...
-
bioRxiv - Neuroscience 2021Quote: ... DIV12-13 neurons were pre-treated for 20 minutes with 40 ng/ml of the CXCR2 (CXCL1 receptor in neurons) antagonist SB225002 (Tocris Bioscience), prior to the addition of 40 nM recombinant mouse CXCL1 (R&D Systems ...
-
bioRxiv - Neuroscience 2021Quote: The contribution of activity-dependent incorporation of GluA1 subunit containing AMPA receptors to expression of low repeat t-LTP was verified by postsynaptic application of Pep1-TGL (100 µM, Tocris, Germany) via the patch pipette solution ...
-
bioRxiv - Physiology 2021Quote: ... Picrotoxin (100 µM) was used to block GABAA-receptor-mediated currents and D-2-amino-5-phosphonovalerate (APV; 20 µMm, Tocris Bioscience), and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX ...
-
bioRxiv - Cell Biology 2021Quote: ... B/D medium was supplemented during submerged culture with 1 nM EC23 (light-stable retinoic acid receptor agonist; Tocris, Abingdon, UK). After confluence was reached ...
-
bioRxiv - Cell Biology 2021Quote: ... AMPAR- and NMDAR-EPSC postsynaptic currents were pharmacologically isolated by adding the GABAA receptor blocker picrotoxin (50 μM) (Tocris Cat#1128) to the extracellular bath solution ...
-
bioRxiv - Neuroscience 2023Quote: ... Experiments were performed at room temperature in oxygenated ACSF containing 50 μM of the GABAA receptor antagonist picrotoxin (Tocris, Ellisville, MO). Recordings from synapses that were silent (failure of transmission at -70 mV ...
-
bioRxiv - Neuroscience 2023Quote: ... and 10 µM 6-imino-3-(4-methoxyphenyl)-1(6H)-pyridazinebutanoic acid hydrobromide (SR95531;GABAA receptor antagonist; all from Tocris Bioscience).
-
bioRxiv - Neuroscience 2021Quote: ... a specific inhibitor of NKCC1 was co-injected with LPS (50 μM; #3108, Tocris). At 24h ...
-
bioRxiv - Genomics 2022Quote: ... The co-cultures were treated with Picrotoxin (10, 25 or 33 μM, TOCRIS #1128), SIS3 (10 μM ...
-
bioRxiv - Neuroscience 2021Quote: ... The bath solution usually contained 6,7-dinitroquinoxaline-2,3-dione (DNQX, 10 µM) and D- aminophosphonovaleric acid (D-APV, 50 µM) to block ionotropic glutamate receptors (Tocris, Abingdon, United Kingdom). Patch electrodes had resistances of 4-6 MΩ when filled with KMeSO4- or CMeSO4-based internal solution (same as used in vivo) ...
-
bioRxiv - Physiology 2020Quote: ... The MOR antagonist CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2, lidocaine, the Ampakine CX614, and the 5-HT4A receptor agonist BIMU8 were obtained from Tocris (ON, Canada).
-
bioRxiv - Neuroscience 2022Quote: ... these experiments were performed in the presence of AMPA and NMDA receptor blockade (10 µM NBQX and 50 µM D-AP5 respectively; Tocris, Bristol, UK). To isolate excitatory currents ...
-
bioRxiv - Neuroscience 2023Quote: ... [Cl-]i measurements were performed by activating either GABAA or glycine receptors by delivering short ‘puffs’ of GABA (Tocris Bioscience, 100 μM) via a patch pipette placed in the vicinity of the cell soma and connected to a picospritzer (5–10 psi for 20– 40 ms ...
-
bioRxiv - Systems Biology 2019Quote: ... ENR media was changed to include additional factors for each cell type specific condition: 3μM CHIR99021 (Tocris) and 10μM DAPT (Tocris ...
-
bioRxiv - Immunology 2023Quote: ... Inhibition of the MyD88-pathway was investigated by co-incubating 1 µM SCIO 469 (TOCRIS), 5 µM SP600125 (Sigma) ...
-
bioRxiv - Neuroscience 2021Quote: ... were dissolved in magnesium-free HEPES-aCSF in the presence of non-NMDA glutamate receptor blockers (CNQX, Tocris, 0190, 40 μM; Nimodipine, Tocris, 0600, 1 μM; LY-367385, Sigma, L4420, 100 μM; MPEP, Tocris, 1212, 10 μM). Type I mGluR agonist DHPG (Tocris ...
-
bioRxiv - Neuroscience 2021Quote: ... [Cl-]i measurements were performed by activating either GABAA or glycine receptors by delivering short ‘puffs’ of either GABA (Tocris Bioscience, 100 μM) or glycine (Tocris Bioscience ...
-
bioRxiv - Neuroscience 2023Quote: ... were dissolved in HEPES-aCSF in the presence of non-NMDA glutamate receptor blockers (CNQX, Tocris, 0190, 40 µM; Nimodipine, Tocris, 0600, 1 µM; LY-367385, Sigma, L4420, 100 µM; MPEP, Tocris, 1212, 10 µM). Type I mGluR agonist DHPG (Tocris ...
-
bioRxiv - Neuroscience 2024Quote: ... a third group of animals were treated as those in group 2 with the addition of CB1 receptor antagonist AM251 (1 µM) (Tocris Bioscience, Bristol, UK). After 8 DIV ...
-
bioRxiv - Physiology 2019Quote: The GLP-1 peptide was purchased from Alta Biosciences(54) and the GIP from Tocris Biosciences ...
-
bioRxiv - Neuroscience 2021Quote: ... was dissolved in HEPES-aCSF in the presence of non-mGluR glutamate receptor blockers (CNQX, Tocris, 0190, 40 μM; Nimodipine, Tocris, 0600, 1 μM; D(-)-2-Amino-5 phosphonopentanoic acid (APV) ...
-
bioRxiv - Neuroscience 2020Quote: ... The bath solution for recordings contained elevated concentrations of divalent cations [4 mM Ca2+ and 4 mM Mg2+] and NMDA receptor antagonist 3-(2-Carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) [5 mM] (Tocris biosciences, 126453-07-4). Slices were used 1.5–4.5 hours after preparation ...
-
bioRxiv - Neuroscience 2019Quote: ... surgeries a single dose (0,6 mg/kg dissolved in phosphate buffer or saline) of P2Y12 receptor (P2Y12R) antagonist (PSB0739 Tocris, R&D Systems, Minneapolis, USA) was administered to the cisterna magna in 5 µl final volume using a glass capillary ...
-
bioRxiv - Neuroscience 2023Quote: ... was dissolved in HEPES-aCSF in the presence of non-mGluR glutamate receptor blockers (CNQX, Tocris, 0190, 40 µM; Nimodipine, Tocris, 0600, 1 µM; D(-)-2-Amino-5 phosphonopentanoic acid (APV) ...
-
bioRxiv - Molecular Biology 2023Quote: The specificity of BRD2 recruitment to the proteasome was assayed by co-treatment with JQ1 (Tocris 4499), the BET inhibitor that was used as a TP ligand in the Halo-UIDs ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: Lyophilized and HPLC-purified Human β-Amyloid1-42 (Aβ1-42) peptide was purchased from Tocris (#1428). 1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP ...
-
bioRxiv - Neuroscience 2023Quote: ... The following peptides were delivered in 5 µL of sterile saline: GRP (295 ng, Tocris 1789), Substance P (400 ng ...